Kenya vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin

Kenya
63.13
in 2021
Trinidad and Tobago
59.38
in 2021
Kenya rank
107th
Trinidad and Tobago rank
110th

The number of people with susceptibility test result for rifampicin over time

  • Kenya
  • Trinidad and Tobago
020406080100201720192021

How they compare

Kenya currently reports 63.13 against 59.38 in Trinidad and Tobago, a difference of 3.75.

That makes Kenya's figure about 1.1 times Trinidad and Tobago's.

The two have swapped places 2 times across 5 shared years of data; in 2017 it was Kenya ahead.

Kenya ranks 107th and Trinidad and Tobago ranks 110th of 146 countries.

Across the 2 decades both report, Kenya averaged higher in 1 and Trinidad and Tobago in 1.

Head to head by decade

Decade Kenya Trinidad and Tobago Difference Ahead
2010s 68.03 73.58 5.54 Trinidad and Tobago
2020s 74.02 66.49 7.53 Kenya

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Kenya or Trinidad and Tobago?
Kenya, at 63.13 against 59.38 in Trinidad and Tobago as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Kenya and Trinidad and Tobago?
3.75, with Kenya ahead.
How many years of comparable data are there for Kenya and Trinidad and Tobago?
5 years are reported by both, from 2017 to 2021.
How do Kenya and Trinidad and Tobago rank globally for the number of people with susceptibility test result for rifampicin?
Kenya ranks 107th and Trinidad and Tobago ranks 110th of 146 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Kenya vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/kenya/trinidad-and-tobago/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/kenya/trinidad-and-tobago/">Kenya vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed